Moderna shares are trading lower after TD Cowen maintained an Outperform rating on the stock and lowered its price target from $175 to $165.
Portfolio Pulse from Benzinga Newsdesk
Moderna's stock is trading lower after TD Cowen maintained an Outperform rating but lowered its price target from $175 to $165.
July 24, 2023 | 4:49 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
TD Cowen has maintained an Outperform rating on Moderna but lowered its price target from $175 to $165, leading to a decrease in the stock's trading price.
The decrease in Moderna's price target by TD Cowen, despite maintaining an Outperform rating, has led to a decrease in the stock's trading price. This suggests that the market has reacted negatively to the lowered price target.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100